Neurological aspects of SARS-COV-2 and the challenges and perspectives of physiotherapy: literature review
DOI:
https://doi.org/10.34024/rnc.2022.v30.12983Keywords:
SARS-CoV-2, Neurological Manifestations, COVID-19, Neurofunctional Physical TherapyAbstract
Introduction. SARS-CoV 2 has been associated with neurological manifestations and physical rehabilitation in these times, plays an important role in the care of these critically ill patients until hospital discharge, aiming at functional recovery after the acute phase of the disease. Objective: Investigate the neurological aspects resulting from COVID-19 and describe the challenges and perspectives of neurofunctional physical therapy in improving the quality of life of these individuals. Method. A bibliographic review was carried out on reliable databases such as PubMed, SciELO, Science Direct, PMC, and PEDro platform. Results. It was selected 12 clinical trials. The authors report that thromboembolic events are considered the greatest predictor of death, with stroke being the most affected, as well as that neurological manifestations occurred at the beginning of the disease. Physical therapy demonstrates that the length of stay was a significant predictor of improvement in muscle strength and functional status, when compared to the total length of stay. Conclusions. The neurological manifestations associated with COVID-19 had a great impact on public health and that it is up to neurofunctional physiotherapists to promote quality of life, returning functionality to these individuals.
Metrics
References
Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019 A Review. JAMA Neurol 2020;77:1018-27. https://doi:10.1001/jamaneurol.2020.2065
Guimarães P, Coelho P. SARS-CoV-2, COVID-19 e Epilepsia. Rev Sinapse 2020;20:43-9. https://doi.org/10.46531/ sinapse/AR/COVID19/ GuimaraesP/2020
Ellul M, Benjamin L, Singh B, Lant S, Michael B, Easton A, et al. Neurological Associations of COVID-19. The Lancet Neurol 2020;19:767-83. https://doi.org/10.1016/S1474-4422(20)30221-0
Yang Y, Xiao Z, Ye K, He X, Sun B, Qin Z, et al. SARS-CoV-2: Characteristics and current advances in research. Rev Virol 2020;17:1-17. https://doi.org/10.1186/s12985-020-01369-z
Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun 2020;109:102433. https://doi.org/10.1186/s12985-020-01369-z
Ellul M, Varatharaj A, Nicholson TR, Pollak TA, Thomas N, Easton A, et al. Defining causality in COVID-19 and neurological disorders. J Neurol Neurosurg Psychiatr 2020;91:811-2. http://dx.doi.org/10.1136/jnnp-2020-323586
Accorsi DX, Santos IAM, Accorsi JX, Bohac S, Chin CM. COVID-19 e o Sistema Nervoso Central. Rev Ul J Med 2020;1:81-7. http://189.112.117.16/index.php/ulakes/article/view/271
Condezo GC. Fisioterapia en tiempos de COVID-19 [editorial]. Rev Hered Rehab 2020;3:1-2. https://doi.org/10.20453/rhr.v3i1.3719
Wade DT. Rehabilitation after COVID-19: an evidence-based approach. Clin Med 2020;20:359-64. https://doi.org/10.7861/clinmed.2020-0353
Kalirathinam D, Guruchandran R, Subramani P. Comprehensive physiotherapy management in covid-19 – a narrative review. Cientia Medica 2020;30:1-9. http://dx.doi.org/10.15448/1980-6108.2020.1.38030
Kemp HI, Corner E, Colvin LA. Chronic pain after COVID-19: implications for rehabilitation. Br J Anaesth 2020;125:436-49. https://doi.org/10.1016/j.bja.2020.05.021
Murieta ES, Supervia M. COVID-19 y cronicidad. Una oportunidad de reinventarlos servicios de Medicina Física y Rehabilitación. Rehabilitacion 2020;54:231-3. https://doi.org/10.1016/j.rh.2020.05.002
Melo LP. Fase crônica da COVID-19: desafios do fisioterapeuta diante das manifestações neurológicas [editorial]. Fisioter Mov 2020;33:1-3. https://doi.org/10.1590/1980-5918.033.ed03
Li Y, Li M, Wang M, Zhou Y, Chang J, Xian Y, et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vas Neurol 2020;5:279-84.
https://doi.org/10.1136/svn-2020-000431
Kihira S, Schefflein J, Chung M, Mahmoudi K, Rigney B, Delman N BN, et al. Incidental COVID-19 related lung apical findings on stroke CTA during the COVID-19 pandemic. J NeuroInterventional Surgery 2020;12:669-72. http://dx.doi.org/10.1136/neurintsurg-2020-016188
Lodigiani C, Lapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res 2020;191:9-14. https://doi.org/10.1016/j.thromres.2020.04.024
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020;77:683-90. https://doi.org/10.1001/jamaneurol.2020.1127
Yaghi S, Ishida K, Torres J, Grory BM, Raz E, Humbert K, et al. SARS2-CoV-2 and stroke in a New York healthcare system. Stroke 2020;51:1-10. https://doi.org/10.1161/strokeaha.120.030335
Dogra S, Jain R, Cao M, Bilaloglu S, Zagzad D, Hochman S, et al. Hemorrhagic stroke and anticoagulation in COVID-19. J Stroke Cerebrovascular Diseases 2020;29:1-6. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104984
Helms J, Tacquard C, Severac F, Leonard LI, Ohana M, Delabranchex, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 2020;46:1-10. https://doi.org/10.1007/s00134-020-06062-x
Moriguchi T, Harii N, Goto J, Harada D, SugawaraA H, Takamino J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infectious Diseases 2020;94:55-8. https://doi.org/10.1016/j.ijid.2020.03.062
Abdelnour L, Adballa ME, Babiker S. COVID 19 infection presenting as motor peripheral neuropathy. J Formos Med Assoc 2020;119:1119–20. https://doi.org/10.1016/j.jfma.2020.04.024
Sedaghat Z, Karimi N. Guillain Barre syndrome associated with COVID-19 infection: a case report. J Clinical Neuroscience 2020;76:233-5. https://doi.org/10.1016/j.jocn.2020.04.062
Filavot A, Sharma P, Hindi F, Espinosa PS. Neurological complications of coronavirus disease (COVID-19): encephalopathy. Cureus 2020;12:1-6. https://doi.org/10.7759/cureus.7352
Gill I, Chan S, Fitzpatrick D. COVID-19 Associated Pulmonary and Cerebral Thromboembolic Disease. Radiol Case Rep 2020;15:1242-9. https://doi.org/10.1016/j.radcr.2020.05.034
Li Y, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients. J Med Virol 2020;92:552-5. https://doi.org/10.1002/jmv.25728
Desforges M, Coupanec AL, Dubeau F, Bourgouin A, Lajoie L, Dubé M, et al. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses 2019;12:1-28. http://dx.doi.org/10.3390/v12010014
Bertoldi ALS, Israel VL, Ladewig I. Efeitos da atenção dirigida para parâmetros da qualidade de movimento na recuperação neurofuncional: relato de caso. Fisioter em Movim 2008;21:19-25. https://periodicos.pucpr.br/index.php/fisio/article/view/19129/18473
Sheehy LM. Considerations for postacute rehabilitation for survivors of COVID-19. JMIR Health Surveill 2020;6:1-8. https://doi.org/10.2196/19462
Ferreira NA, Lopes AJ, Ferreira AS, Ntoumenopoulos G, Dias J, Guimaraes FS. Determination of functional prognosis in hospitalized patients following an intensive care admission. World J Critical Care Med 2016;5:219-27. https://doi.org/10.5492/wjccm.v5.i4.219000
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Nayara Marques, Ivair Matias Júnior
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
Accepted 2022-06-09
Published 2022-08-02
